Next Article in Journal
Poly(l-Lactic Acid)-co-poly(Butylene Adipate) New Block Copolymers for the Preparation of Drug-Loaded Long Acting Injectable Microparticles
Next Article in Special Issue
Ophthalmic In Situ Gels with Balsam Poplar Buds Extract: Formulation, Rheological Characterization, and Quality Evaluation
Previous Article in Journal
Folic Acid-Targeted Paclitaxel-Polymer Conjugates Exert Selective Cytotoxicity and Modulate Invasiveness of Colon Cancer Cells
Previous Article in Special Issue
Studying the Impact of the Temperature and Sorbed Water during Microwave-Induced In Situ Amorphization: A Case Study of Celecoxib and Polyvinylpyrrolidone
Article

Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression

1
Department of Animal Physiology and Development, Faculty of Biology, Adam Mickiewicz University in Poznań, 61614 Poznań, Poland
2
NanoBioMedical Centre, Adam Mickiewicz University in Poznań, 61614 Poznań, Poland
3
Department of Biochemistry, Molecular Biology and Biotechnology, Faculty of Chemistry, Wrocław University of Science and Technology, 50370 Wrocław, Poland
4
Department of Perinatology and Gynecology, Poznań University of Medical Sciences, 60535 Poznań, Poland
5
Chair and Department of Cell Biology, Poznań University of Medical Sciences, 60806 Poznań, Poland
6
Department of General and Colorectal Surgery, Poznań University of Medical Sciences, 61285 Poznań, Poland
7
Laboratory of Environmental Research, Department of Toxicology, Poznań University of Medical Sciences,60631 Poznań, Poland
8
Department of Medical Education, Poznań University of Medical Sciences, 60806 Poznań, Poland
9
Molecular Virology Research Unit, Adam Mickiewicz University in Poznań, 61614 Poznań, Poland
*
Author to whom correspondence should be addressed.
Academic Editors: Donatella Paolino and Cinzia Anna Ventura
Pharmaceutics 2021, 13(7), 931; https://doi.org/10.3390/pharmaceutics13070931
Received: 14 May 2021 / Revised: 14 June 2021 / Accepted: 16 June 2021 / Published: 23 June 2021
(This article belongs to the Collection Women in Pharmaceutics)
Endometriosis is a gynecological disease defined by the presence of endometrial tissue outside the uterus. To date, the effective treatment of this disease is still based on invasive surgery or laparoscopy. Chelidonium majus L. (Papaveraceae) belongs to medicinal, latex-bearing plants. Extracts from the plant are a rich source of pharmacologically active agents. Protoberberine compounds derived from C. majus possess anticancer and antiproliferative activities. In the present study of a rat model of endometriosis, we investigated the influence of the plant protoberberine-rich fraction (BBR) obtained from the medicinal plant C. majus on the development of endometriosis. To understand of BBR therapeutic potential for endometriosis, metabolomics has been applied to study. BBR was prepared from an ethanolic extract of dry plants C. majus. Rats (n = 16) with confirmed endometriosis were treated with BBR administered orally (1 g/kg) for 14 days. Blood serum samples were collected from all of the animals and metabolites were studied using the NMR method. The metabolomic pattern was compared before and after the protoberberine treatment. The performed analysis showed significant changes in the concentrations of metabolites that are involved in energy homeostasis, including glucose, glutamine, and lactate. Histopathological studies showed no recurrence of endometriosis loci after treatment with BBR. The results of the study found that BBR treatment prevents the recurrence of endometriosis in rats. Moreover, metabolomics profiling can be applied to better understand the mechanisms of action of these protoberberine secondary plant metabolites. Our findings provide new insights into the pharmaceutical activity of natural protoberberine plant compounds. View Full-Text
Keywords: protoberberine compounds; berberine; Chelidonium majus L.; endometriosis; metabolomics protoberberine compounds; berberine; Chelidonium majus L.; endometriosis; metabolomics
Show Figures

Figure 1

MDPI and ACS Style

Warowicka, A.; Qasem, B.; Dera-Szymanowska, A.; Wołuń-Cholewa, M.; Florczak, P.; Horst, N.; Napierała, M.; Szymanowski, K.; Popenda, Ł.; Bartkowiak, G.; Florek, E.; Goździcka-Józefiak, A.; Młynarz, P. Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression. Pharmaceutics 2021, 13, 931. https://doi.org/10.3390/pharmaceutics13070931

AMA Style

Warowicka A, Qasem B, Dera-Szymanowska A, Wołuń-Cholewa M, Florczak P, Horst N, Napierała M, Szymanowski K, Popenda Ł, Bartkowiak G, Florek E, Goździcka-Józefiak A, Młynarz P. Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression. Pharmaceutics. 2021; 13(7):931. https://doi.org/10.3390/pharmaceutics13070931

Chicago/Turabian Style

Warowicka, Alicja, Badr Qasem, Anna Dera-Szymanowska, Maria Wołuń-Cholewa, Patryk Florczak, Nikodem Horst, Marta Napierała, Krzysztof Szymanowski, Łukasz Popenda, Grażyna Bartkowiak, Ewa Florek, Anna Goździcka-Józefiak, and Piotr Młynarz. 2021. "Effect of Protoberberine-Rich Fraction of Chelidonium majus L. on Endometriosis Regression" Pharmaceutics 13, no. 7: 931. https://doi.org/10.3390/pharmaceutics13070931

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop